0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover161.82%IV-17.42%PremiumDec 20, 2024Expiry Date2.11Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7558Delta0.0666Gamma4.07Leverage Ratio-0.0361Theta0.0036Rho3.08Eff Leverage0.0091Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet